Administration Eases Rules to Give Laid-Off Workers More Time to Sign Up for COBRA
(By Michelle Andrews for Kaiser Health News) People who’ve been laid off or furloughed from their jobs now have significantly more
Read More
Florida to open 120-bed center for COVID-19 patients
(By Gabrielle Masson for Becker’s Hospital Review) Florida officials are finalizing plans for a “super-skilled nursing facility” that will accept COVID-19
Read MoreHouse bill would secure telehealth expansions after pandemic: 4 things to know
(By Jackie Drees for Becker’s Hospital Review) A group of bipartisan lawmakers introduced a bill in the U.S. House July 16
Read MoreWhy the large premium hikes to your LTC policy and what to do about it
Many long-term care (LTC) policy holders may be facing a sizable premium increase this year causing many to doubt if
Read MoreHospitals Overbilled Medicare $1 Billion by Incorrectly Assigning Severe Malnutrition Diagnosis Codes to Inpatient Hospital Claims
(Source – oig.hhs.gov) Nutritional marasmus (diagnosis code E41) and unspecified severe protein-calorie malnutrition (diagnosis code E43) are two types of severe
Read MoreThe Beneficiary Enrollment Notificaiton and Eligibilty Act
For the first time in 50 years, legislation was approved by the House committee that would make changes to the
Read MoreMore education is needed on how to best utilize HSAs
The results from a recent survey conducted by Optum Bank and Empower Retirement found although HSAs provide a variety of
Read MoreCancer patient deaths lower at higher CMS-rated hospitals, study finds
(By Anuja Vaidya for Becker’s Hospital Review) Death rates after complex cancer surgery were linked to a hospital’s star rating designated
Read MoreWalmart has started offering health plan options
According to a local news outlet in Arkansas, Walmart Insurance Services LLC has officially filed to conduct business in the
Read MoreDozens of patents protect AbbVie’s pricey cancer drug against competition, report finds
(By Katie Adams for Becker’s Hospital Review) AbbVie wields at least 88 patents to guard Imbruvica, its expensive cancer treatment, against competition from
Read More